This article relies largely or entirely on a single source . Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Metaproscaline" – news · newspapers · books · scholar · JSTOR (November 2022) |
| Names | |
|---|---|
| IUPAC name 2-(3,4-dimethoxy-5-propoxyphenyl)ethanamine | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider |
|
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C13H21NO3 | |
| Molar mass | 239.311 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Metaproscaline, or 3,4-dimethoxy-5-propoxyphenethylamine, is a lesser-known psychedelic drug. It is an analog of proscaline. Metaproscaline was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved) , the dosage and the duration are unknown. [1] Metaproscaline produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of metaproscaline.
| | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |
